Table 2

Genetic risk factors for SVT (thrombophlebitis) in patients and controls in the MEGA study

Patients, thrombophlebitis
Controls, thrombophlebitis
Yes (n)No (n)Crude odds ratio (95% CI)Adjusted odds ratio (95% CI)*Yes, nNo, nCrude odds ratio (95% CI)Adjusted odds ratio (95% CI)*
Blood group O 96 1034 Reference Reference 40 2109 Reference Reference 
Blood group non-O 286 2509 1.2 (1.0-1.6) 1.3 (1.0-1.6) 61 2457 1.3 (0.9-2.0) 1.3 (0.9-2.0) 
No factor V Leiden 290 3020 Reference Reference 94 4324 Reference Reference 
Factor V Leiden 97 532 1.9 (1.5-2.4) 2.0 (1.6-2.6) 244 1.3 (0.6-2.9) 1.5 (0.7-3.3) 
No prothrombin G20210A 361 3373 Reference Reference 99 4478 Reference Reference 
Prothrombin G20210A 26 182 1.3 (0.9-2.0) 1.3 (0.9-2.0) 91 1.0 (0.2-4.1) 0.9 (0.2-3.7) 
Patients, thrombophlebitis
Controls, thrombophlebitis
Yes (n)No (n)Crude odds ratio (95% CI)Adjusted odds ratio (95% CI)*Yes, nNo, nCrude odds ratio (95% CI)Adjusted odds ratio (95% CI)*
Blood group O 96 1034 Reference Reference 40 2109 Reference Reference 
Blood group non-O 286 2509 1.2 (1.0-1.6) 1.3 (1.0-1.6) 61 2457 1.3 (0.9-2.0) 1.3 (0.9-2.0) 
No factor V Leiden 290 3020 Reference Reference 94 4324 Reference Reference 
Factor V Leiden 97 532 1.9 (1.5-2.4) 2.0 (1.6-2.6) 244 1.3 (0.6-2.9) 1.5 (0.7-3.3) 
No prothrombin G20210A 361 3373 Reference Reference 99 4478 Reference Reference 
Prothrombin G20210A 26 182 1.3 (0.9-2.0) 1.3 (0.9-2.0) 91 1.0 (0.2-4.1) 0.9 (0.2-3.7) 

CI indicates confidence interval; MEGA, Multiple Environmental and Genetic Assessment of risk factors for venous thrombosis; and SVT, superficial vein thrombosis..

*

Adjusted for age and sex.

or Create an Account

Close Modal
Close Modal